Spatial transcriptomic characterization of pathologic niches in IPF
Christoph H Mayr1, Diana Santacruz2, Sebastian Jarosch3
1Boehringer Ingelheim Pharma GmbH & Co. KG, Department Immunology and Respiratory Disease research, Birkendorfer Straße 65, 88397 Biberach an der Riß, Germany.
Science Advances
|August 9, 2024
Summary
Spatial transcriptomics reveals distinct disease-associated niches in idiopathic pulmonary fibrosis (IPF). This study identifies fibrotic, airway macrophage, and immune niches, offering new targets for antifibrotic therapies and in vitro models.
Area of Science:
- Pulmonary Medicine
- Genomics
- Cell Biology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
- Single-cell RNA sequencing (scRNA-seq) has advanced IPF research but lacks spatial context.
- Spatial transcriptomics offers gene expression localization within lung tissue.
Purpose of the Study:
- To spatially characterize disease-associated niches in IPF lung tissue.
- To integrate spatial transcriptomics data with an existing IPF scRNA-seq atlas.
- To identify novel therapeutic targets and improve in vitro models for IPF.
Main Methods:
- Profiling IPF and control patient lung tissue using spatial transcriptomics.
- Integrating spatial transcriptomics data with a single-cell RNA sequencing (scRNA-seq) atlas of IPF.
- Analyzing cellular composition and localization within identified disease niches.
Main Results:
- Identification of three distinct disease-associated niches in IPF lungs: a fibrotic niche, an airway macrophage niche, and an immune niche.
- The fibrotic niche contains myofibroblasts and basaloid cells near airways.
- The airway macrophage niche features SPP1+ macrophages, and the immune niche shows lymphoid cell foci near remodeled vessels.
Conclusions:
- Spatial transcriptomics provides crucial cellular and tissue context for IPF.
- The identified IPF niches offer potential targets for antifibrotic drug development.
- This spatial mapping aids in creating more disease-relevant in vitro models for IPF research.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
904
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
904
Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K


